[Dosage equivalents of AT1-receptor antagonists available in Germany].
Dominiak
P
P
Institut für experimentelle und klinische Pharmakologie und Toxikologie, Universitätsklinikum Schleswig-Holstein, Campus Lübeck. dominiak@medinf.mu-luebeck.de
Häuser
W
W
D000179:Acrylates / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D000803:Angiotensin I / Q000037:antagonists & inhibitors*; D000804:Angiotensin II / Q000037:antagonists & inhibitors*; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage* / Q000493:pharmacokinetics* / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics* / Q000627:therapeutic use; D001562:Benzimidazoles / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D001565:Benzoates / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D001713:Biphenyl Compounds / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005858:Germany; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007093:Imidazoles / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D000077405:Irbesartan; D019808:Losartan / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D000068557:Olmesartan Medoxomil; D010919:Placebos; D000077333:Telmisartan; D013777:Tetrazoles / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D013810:Therapeutic Equivalency; D013876:Thiophenes; D013997:Time Factors; D014633:Valine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000627:therapeutic use; D000068756:Valsartan
D000179:Acrylates; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001565:Benzoates; D001713:Biphenyl Compounds; D007093:Imidazoles; D010919:Placebos; D013777:Tetrazoles; D013876:Thiophenes; D000804:Angiotensin II; C068373:eprosartan; D000068557:Olmesartan Medoxomil; D000068756:Valsartan; D000803:Angiotensin I; C066026:losartan carboxylic acid; D014633:Valine; D000077405:Irbesartan; D019808:Losartan; C081643:candesartan; D000077333:Telmisartan